Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

NCT00511108 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: Comparator: sitagliptin phosphate
DRUG: Comparator: pioglitazone
DRUG: Comparator: placebo to pioglitazone
DRUG: Comparator: placebo to sitagliptin

Sponsor

Merck Sharp & Dohme LLC